![018 Open-Label Pilot, Prospective Vulvoscopic Study During Four Months of Administration of Daily Prasterone (6.5 mg DHEA) Vaginal Inserts in Women with Moderate to Severe Dyspareunia from Vulvar Vaginal Atrophy (VVA) Due 018 Open-Label Pilot, Prospective Vulvoscopic Study During Four Months of Administration of Daily Prasterone (6.5 mg DHEA) Vaginal Inserts in Women with Moderate to Severe Dyspareunia from Vulvar Vaginal Atrophy (VVA) Due](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a27c5200-389c-4ca6-b0d6-2f723e015b0b/fx1_lrg.jpg)
018 Open-Label Pilot, Prospective Vulvoscopic Study During Four Months of Administration of Daily Prasterone (6.5 mg DHEA) Vaginal Inserts in Women with Moderate to Severe Dyspareunia from Vulvar Vaginal Atrophy (VVA) Due
![MonnalisaTouch™: Una nuova terapia laser vaginale efficace e indolore per il trattamento dell'atrofia vaginale in gravidanza e non solo | www.ginecologadelbravo.it MonnalisaTouch™: Una nuova terapia laser vaginale efficace e indolore per il trattamento dell'atrofia vaginale in gravidanza e non solo | www.ginecologadelbravo.it](https://www.ginecologadelbravo.it/sites/default/files/styles/100__outputs/public/Laser%20terapia%20Pisa%20MonnaLisa%20Touch%20Barbara%20Del%20Bravo%20Vista%20Vision_cos%27%C3%A8%20il%20laser.jpg?itok=h7ceVCym)
MonnalisaTouch™: Una nuova terapia laser vaginale efficace e indolore per il trattamento dell'atrofia vaginale in gravidanza e non solo | www.ginecologadelbravo.it
![Atrofia vulvovaginale e sindrome genitourinaria della menopausa - Ginecologia - Alessandra Graziottin Atrofia vulvovaginale e sindrome genitourinaria della menopausa - Ginecologia - Alessandra Graziottin](https://www.alessandragraziottin.it/ew/ew_schede/images/lt_scheda/imageset/big_dalie.jpg)